Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hemachandra Reddy

Showing results (41-50 of 278) with videos related to

Pageof 28
Sort By:
Journal of Alzheimer'S Disease : JAD|February 18, 2017
Therapeutics of Neurotransmitters in Alzheimer's DiseaseRamesh Kandimalla, P Hemachandra Reddy
Biochimica Et Biophysica Acta|September 26, 2013
RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activityMaria Manczak, P Hemachandra Reddy
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease NeuronsRavi Rajmohan, P Hemachandra Reddy
Human Molecular Genetics|October 15, 2015
Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's diseaseMaria Manczak, P Hemachandra Reddy
Biochimica Et Biophysica Acta|June 7, 2016
Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?Subodh Kumar, P Hemachandra Reddy
Frontiers in Aging Neuroscience|March 13, 2018
MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An UpdateSubodh Kumar, P Hemachandra Reddy
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Role of Glutamate and NMDA Receptors in Alzheimer's DiseaseRui Wang, P Hemachandra Reddy
Biochimica Et Biophysica Acta|May 10, 2011
Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damageMarcus J Calkins, P Hemachandra Reddy
Drug Discovery Today|November 7, 2016
Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisalChandra Sekhar Kuruva, P Hemachandra Reddy
Trends in Molecular Medicine|January 26, 2008
Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's diseaseP Hemachandra Reddy, M Flint Beal
Pageof 28

Showing results (41-50 of 278) with videos related to

Sort By:
Pageof 28
Journal of Alzheimer'S Disease : JAD|February 18, 2017
Therapeutics of Neurotransmitters in Alzheimer's DiseaseRamesh Kandimalla, P Hemachandra Reddy
Biochimica Et Biophysica Acta|September 26, 2013
RNA silencing of genes involved in Alzheimer's disease enhances mitochondrial function and synaptic activityMaria Manczak, P Hemachandra Reddy
Journal of Alzheimer'S Disease : JAD|August 29, 2016
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease NeuronsRavi Rajmohan, P Hemachandra Reddy
Human Molecular Genetics|October 15, 2015
Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's diseaseMaria Manczak, P Hemachandra Reddy
Biochimica Et Biophysica Acta|June 7, 2016
Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?Subodh Kumar, P Hemachandra Reddy
Frontiers in Aging Neuroscience|March 13, 2018
MicroRNA-455-3p as a Potential Biomarker for Alzheimer's Disease: An UpdateSubodh Kumar, P Hemachandra Reddy
Journal of Alzheimer'S Disease : JAD|September 24, 2016
Role of Glutamate and NMDA Receptors in Alzheimer's DiseaseRui Wang, P Hemachandra Reddy
Biochimica Et Biophysica Acta|May 10, 2011
Assessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damageMarcus J Calkins, P Hemachandra Reddy
Drug Discovery Today|November 7, 2016
Amyloid beta modulators and neuroprotection in Alzheimer's disease: a critical appraisalChandra Sekhar Kuruva, P Hemachandra Reddy
Trends in Molecular Medicine|January 26, 2008
Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's diseaseP Hemachandra Reddy, M Flint Beal
Pageof 28